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Abstract
Cellular immunity to Mycobacterium tuberculosis (Mtb) requires a coordinated response between the innate and adaptive
arms of the immune system, resulting in a type 1 cytokine response, which is associated with control of infection. The
contribution of innate lymphocytes to immunity against Mtb remains controversial. We established an in vitro system to
study this question. Interferon-c is produced when splenocytes from uninfected mice are cultured with Mtb-infected
macrophages, and, under these conditions, bacterial replication is suppressed. This innate control of bacterial replication is
dependent on CD1d-restricted invariant NKT (iNKT) cells, and their activation requires CD1d expression by infected
macrophages as well as IL-12 and IL-18. We show that iNKT cells, even in limiting quantities, are sufficient to restrict Mtb
replication. To determine whether iNKT cells contribute to host defense against tuberculosis in vivo, we adoptively
transferred iNKT cells into mice. Primary splenic iNKT cells obtained from uninfected mice significantly reduce the bacterial
burden in the lungs of mice infected with virulent Mtb by the aerosol route. Thus, iNKT cells have a direct bactericidal effect,
even in the absence of synthetic ligands such as a-galactosylceramide. Our finding that iNKT cells protect mice against
aerosol Mtb infection is the first evidence that CD1d-restricted NKT cells mediate protection against Mtb in vivo.
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Introduction
Cells of the innate immune system use several receptor systems
to recognize pathogens and act as the first line of defense against
infection. In contrast, the expression of clonal antigen receptors
and the capacity to differentiate into memory cells distinguish B
and T lymphocytes as the central components of the adaptive
immune system. Certain T subsets, such as cd T cells and NKT
cells, have features of innate immune cells including a partially
activated phenotype, a rapid response following detection of
infected cells, and the modulation of other cell types [1]. Together
with NK cells, these cell subsets are functionally defined as innate
lymphocytes. While innate lymphocytes serve important roles in
host resistance to different infections, it remains controversial
whether these cells contribute to immunity against Mycobacterium
tuberculosis (Mtb) infection.
Following Mtb infection, NK cells become activated and are
early and rapid producers of interferon-c (IFN-c), a cytokine
critical for the activation of macrophages (MQ) [2,3]. However,
mouse models in which NK cells are defective or are depleted in
vivo have failed to show that NK cells are essential for immunity to
tuberculosis [3]. Similarly, cd T cells are frequently activated by a
variety of pathogens including Mtb [4]. Mice lacking cd T cells
succumb more rapidly than control mice following intravenous
challenge with virulent Mtb; however, such a difference has not
been observed following infection by the aerosol route [5,6].
Although cd T cells may not be required for optimum control of
bacterial replication following pulmonary infection, cd T cell
deficient mice form disorganized granulomas dominated by foamy
MQ and granulocytes instead of lymphocytes [6]. Similarly, while
CD1d-restricted NKT cells rapidly produce large amounts of IFN-
c when activated and play a role in granuloma formation under
certain conditions, there is little evidence to support their
requirement for optimum immunity against Mtb infection,
although their pharmacological activation confers a significant
survival advantage to susceptible mouse strains [7–14].
The mouse model of tuberculosis has been useful in delineating
how different cell types contribute to immunity against Mtb. Many
important components of the human immune response to Mtb were
first identified or have been successfully modeled in the mouse
including the critical role of IL-12, IFN-c, TNF, and CD4
+ T cells.
CD4
+ T cells have unambiguously been identified as the most
important lymphocyte subsetinthemousefor mediating protection.
However, the dominant role of CD4
+ T cells may obscure the
contribution of other immune mechanisms. Factors such as
inoculum size, Mtb strain virulence, and experimental variability
limit the dynamic range of the end points measured and reduce the
capacity to detect subtle defects in immunity. We established an in
vitro model to address whether innate lymphocytes have a role in
immunity against Mtb. In our model, splenocytes obtained from
uninfected mice are cultured with primary MQ infected with
virulent Mtb. Under these conditions, splenocytes secrete IFN-c,
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intracellular Mtb replication. In this report, we identify the cellular
mechanism that mediates this innate effector function against the
intracellular human pathogen Mtb.
Results
Splenocytes from Naı ¨ve Mice Are a Source of Innate IFN-c
and Restrict Growth of Mtb
ElicitedperitonealMQwereinfectedwithvirulentMtbfor2hrsas
described in the Methods. The MQ were cultured overnight after
infection, and the next day splenocytes obtained from uninfected
C57BL/6 (B6) mice were added. After 24 hrs, IL-12 was detected in
the supernatant of infected macrophages irrespective of whether
splenocyteswereadded (Figure 1A). In contrast,IFN-c wasdetected
only in the supernatant from cocultures of splenocytes and infected
MQ, but not from cultures of splenocytes and uninfected MQ,n o r
from infected MQ alone (Figure 1B).
Three days after the addition of the splenocytes, the number of
bacteria contained in the cultures was determined. Compared to
infected MQ cultured alone, the addition of splenocytes led to a
54.5% reduction of Mtb CFU (p,0.0001) (Figure 1C). The precise
number of bacteria used to infect the MQ varied between
experiments; therefore, to compare experiments, the data was
normalized based on the CFU recovered from infected MQ 4 days
after in vitro infection. This analysis revealed that co-culture of
naı ¨ve splenocytes with infected MQ led to a 44.163.1% (n=18
experiments) reduction in mycobacterial growth compared to
infected MQ cultured alone (Figure 1D). Thus, infected MQ
stimulated the production of IFN-c by naı ¨ve splenocytes which
correlated with a reduction in the number of Mtb recovered from
the cultures.
Suppression of Mycobacterial Growth by Splenocytes Is T
Cell–Dependent
The main cellular source of IFN-c is NK and T cells. To
determine the cellular basis for control of Mtb replication, we first
determined whether splenocytes from uninfected RAG
2/2 mice,
which lack mature B and T lymphocytes but are enriched for NK
cells, could restrict bacterial growth. Compared to splenocytes
from uninfected B6 mice, splenocytes from B6 RAG
2/2 mice
were unable to reduce mycobacterial CFU (p=0.23) (Figure 2A).
The inability of RAG
2/2 splenocytes to limit Mtb growth
argues that a B or T lymphocyte subset is required to restrict
bacterial replication. To determine which cell type was critical in
this process, splenic T cells (CD90
+) and B cells (CD19
+) were
purified from naı ¨ve B6 mice. Purified B cells (CD19
+), or
splenocytes depleted of T cells (CD90-) were unable to control
mycobacterial growth (p.0.05, compared to infected MQ alone)
(Figure 2B). In contrast, purified T cells (CD90
+), or splenocytes
enriched in T cells (CD19
2) very efficiently controlled bacterial
growth (p,0.05) (Figure 2B). The increased activity of T cells to
control bacterial growth compared to total splenocytes (p,0.05),
strongly suggests that suppression of mycobacterial replication is
dependent on T cells.
To further characterize the T cell subset that restricts bacterial
replication, T cells from spleens of naı ¨ve B6 mice were
fractionated. We compared the ability of purified CD4
+ and
CD4
2 cells to reduce CFU. Our results showed that both CD4
+
and CD4
2 cells control bacterial growth (Figure 2C). However,
Figure 1. Naı ¨ve splenocytes cultured with Mtb-infected MQ
produce IFN-c and suppress bacterial replication. (A) Mtb-
infected MQ secrete IL-12. Uninfected (open bars) and Mtb-infected
(solid bars) were cultured in the presence or absence of splenocytes
(Spln). IL-12p40 was measured after 24 hrs. Bars represent the mean+/
2SD of triplicate cultures. (B) Mtb-infected MQ stimulate IFN-c secretion
by splenocytes. Uninfected (open bars) and Mtb-infected (solid bars)
were cultured in the presence or absence of splenocytes. IFN-c was
measured 24 hrs after coculture. The bars represent the mean+/2SD of
triplicate cultures. (C) Coculture of splenocytes with infected MQ leads
to reduced Mtb replication. Mtb-infected MQ were cultured in the
presence or absence of splenocytes from uninfected mice for 3 days
and then CFU were determined. Bar represents mean+/2SD from
replicate cultures (n=6). (D) Naı ¨ve splenocytes reproducibly suppress
intracellular Mtb replication. To determine the average CFU reduction,
the data from 18 independent experiments were normalized by setting
the CFU recovered from the infected MQ cultured alone to 100%. Bars,
mean6SEM.
doi:10.1371/journal.ppat.1000239.g001
Author Summary
Host resistance to Mycobacterium tuberculosis (Mtb)
requires a coordinated response by the different compo-
nents of the immune system. We established an in vitro
model to study the contribution of innate lymphocytes to
immunity against Mtb. When co-cultured with Mtb-
infected macrophages, splenocytes from uninfected mice
become activated and suppress bacterial replication. By
fractionating the different splenocyte cell populations, we
discovered that the invariant NKT (iNKT) cell is essential for
suppressing intracellular bacterial replication. iNKT cells,
which are conserved in rodents and humans, recognize
lipids presented by the antigen-presenting molecule
CD1d. While we had previously shown that iNKT cell-
deficient mice are not more susceptible to tuberculosis, a
potential contribution of iNKT cells during the early phase
of immunity may have been masked. To address this issue,
we showed that highly purified iNKT cells were sufficient
to reduce the lung bacterial burden of mice infected with
virulent Mtb. This is the first evidence that CD1d-restricted
iNKT cells play a physiological role in mediating protection
against aerosol Mtb infection in vivo. Thus, by being an
early producer of interferon-g and suppressing intracellular
bacterial growth, iNKT cells function as an important part
of the early immune response against Mtb.
iNKT Cells and Tuberculosis
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+ and CD4
2 cells was not
significantly different. While this result may indicate that either
CD4
+ or CD8
+ T cells can restrict mycobacterial growth, this
effect could be dependent upon NKT cells. Although NKT cells
account for only a small fraction of total splenocytes, they can have
either a CD4
+ or CD4
28
2 phenotype, and thus, they would be
predicted to be present in both the CD4
+ and CD4
2 T cell
compartment.
Recognition of Infected MQ by CD1d-Restricted iNKT
Cells Is Required for the Suppression of Mycobacterial
Growth
To test the hypothesis that inhibition of mycobacterial growth is
dependent on CD1d-restricted NKT cells, we tested whether
splenocytes from two different mouse strains that lack NKT cells
could reduce Mtb CFU. CD1d
2/2 mice lack both invariant and
diverse CD1d-restricted NKT cells; in contrast, Ja281
2/2 mice
are deficient only in invariant NKT (iNKT) cells. Naı ¨ve
splenocytes from naı ¨ve CD1d
2/2,J a281
2/2 or WT mice were
cocultured with infected MQ and bacterial growth was measured 3
days later. Compared to WT splenocytes, both CD1d
2/2 and
Ja281
2/2 splenocytes had lost the capacity to control mycobac-
terial replication (p.0.05 compared to MQ alone). Thus, the
ability of splenocytes to limit mycobacterial growth is dependent
upon iNKT cells (Figure 3A)
The requirement for iNKT cells in the control of mycobacterial
growth raised the possibility that these cells were being activated
by the infected MQ. Both CD1d-dependent and CD1d-indepen-
dent mechanisms of iNKT cell activation have been described
[15]. Infection can lead to CD1d-dependent iNKT cell activation
if there is cognate recognition of microbial antigens, or if the
pathogen induces sufficient cytokine production to drive the
activation of self-reactive iNKT cells [16]. To determine whether
the expression of CD1d by the infected MQ was required for
control of bacterial replication by iNKT cells, MQ from CD1d
2/2
and B6 WT mice were infected in vitro. Naı ¨ve splenocytes were
added and bacterial growth was measured 3 days later. Naı ¨ve
splenocytes co-cultured with infected WT MQ reduced the Mtb
CFU by 62% (p,0.05) (Figure 3B). In contrast, no CFU reduction
was observed when the same splenocytes were cultured with
CD1d
2/2 MQ (p, NS). This shows that CD1d expression by the
infected MQ is required for the control of Mtb growth by
splenocytes. Thus, CD1d-restricted recognition between the
infected MQ and the iNKT cell is required for suppression of
bacterial replication.
Both iNKT Cells and Conventional T Cells Become
Activated When Cultured with Mtb-Infected MQ
Activated iNKT cells modulate the activity of other cells
including B and T cells, NK cells, granulocytes, and DC.
Therefore, while the anti-mycobacterial activity of naı ¨ve spleno-
cytes may depend on iNKT cells, iNKT cells may not be sufficient
to mediate bacterial growth restriction. To determine what other
cell types become activated following culture with Mtb-infected
MQ, we measured the expression of the CD69 activation marker
24 hrs after coculture of splenocytes with uninfected or Mtb-
infected MQ. CD69 expression remained low on CD4
+, CD8
+,
and iNKT cells cultured with uninfected MQ (Figure 4, top row).
In contrast, within 24 hrs after culture with infected MQ, iNKT
cells upregulated CD69 expression from 0.4% to 25.2% (Figure 4,
bottom row). Similarly, CD69 expression increased on CD4
+ T
cells from 0.9% to 5.2%, and on CD8
+ T cells from 0.3% to 7.9%
(Figure 4). Splenocytes from CD1d
2/2 mice were analyzed under
these same conditions. Just as with the WT splenocytes,
upregulation of CD69 by CD4
+ and CD8
+ T cells was observed
within 24 hrs after culture with infected MQ (data not shown).
These results show that Mtb-infected MQ stimulate the activation
of iNKT cells, CD4
+ and CD8
+ T cells. However, the induction of
CD69 expression by conventional CD4
+ and CD8
+ T cells is
CD1d-independent.
iNKT Cell Effector Function Is Dependent on IL-12 and IL-
18 Cytokine-Driven Activation
Following Mtb infection, a variety of cytokines are made by
infected MQ, including IL-12 and IL-18, which can drive the
antigen-independent production of IFN-c by T cells. To
Figure 2. Suppression of Mtb replication by splenocytes is T cell–dependent. Statistical testing was done using a one-way ANOVA with
Dunnett’s post-test comparing each experimental group to infected MQ cultured alone. Bars, mean6SEM of replicate cultures (n=6–8). **, ***,
p,0.05; ns, not significant. (A) Splenocytes (spln) from RAG
2/2 mice are unable to limit bacterial replication. Infected MQ were cultured alone or with
splenocytes from uninfected WT or RAG
2/2 mice. Coculture with WT splenocytes but not RAG
2/2 splenocytes led to a significant reduction in
bacterial CFU after 3 days. (B) T cell enriched cellular fractions have increased anti-mycobacterial activity. Infected MQ were cultured alone or with cell
fractions from WT splenocytes (spleen). CD90 and CD19 immunomagnetic beads were used to enrich or deplete T cells or B cells from splenocytes. (C)
Both CD4
+ and CD4
2 cells suppress Mtb replication. Infected MQ were cultured alone or with CD4
+ or CD4
2 cell fractions obtained from WT
splenocytes.
doi:10.1371/journal.ppat.1000239.g002
iNKT Cells and Tuberculosis
PLoS Pathogens | www.plospathogens.org 3 December 2008 | Volume 4 | Issue 12 | e1000239determine whether IL-12 and IL-18 secreted by infected MQ are
required for iNKT cell activation, antibodies to anti-IL-12p40,
anti-IL-18, or both were added to co-cultures of naı ¨ve splenocytes
and infected MQ.
Culture of splenocytes with infected MQ led to the production of
c-interferon (IFN-c) and nitric oxide (NO) in the culture
supernatant (Figure 5A and 5B). These are important mediators
of anti-mycobacterial immunity, and IFN-c is required for optimal
induction of inducible nitric oxide synthase (iNOS), which leads to
intracellular production of NO, an important effector molecule
that ultimately suppresses the growth of Mtb. Blockade of IL-
12p40 or IL-18 significantly abrogated the secretion of IFN-c in
these cultures (Figure 5A). A predictable consequence was a
reduction in NO production (Figure 5B).
In agreement with the reduce secretion of IFN-c and NO,
blockade of IL-12 or IL-18 abrogated control of bacterial
replication. Thus, iNKT cell activation and control of the
bacterial replication was dependent on both IL-12 p40 and IL-
18 (Figure 5C).
iNKT Cells Are Sufficient To Kill Intracellular Mtb
The results presented above show that the ability of splenocytes
to restrict mycobacterial growth is dependent upon iNKT cells.
Because iNKT cells have both direct effector and immunoregu-
latory functions, we next determined whether iNKT cells were
sufficient to restrict the growth of Mtb or whether this effect was
mediated by cross-talk, which activates other cell types to produce
IFN-c. To assess whether invariant NKT cells can directly kill Mtb,
Figure 3. Suppression of bacterial replication requires cognate recognition of Mtb-infected MQ by iNKT cells. Statistical testing was
done using a one-way ANOVA with Dunnett’s post-test comparing each experimental group to infected MQ cultured alone. Bars, mean6SEM of
replicate cultures (n=6–8). *, ***, p,0.05; ns, not significant. (A) The presence of iNKT cells is required for the Mtb suppressive activity of splenocytes.
Infected MQ were cultured alone or with splenocytes (spln) from WT, CD1d
2/2, or Ja281
2/2 mice. Only addition of WT splenocytes led to a significant
reduction in CFU. (B) CD1d expression by Mtb-infected MQ is required for the control of bacterial replication. MQ obtained from WT (left) or CD1d
2/2
(right) mice were infected with Mtb. Infected MQ were cocultured with WT splenocytes (spln). Addition of splenocytes to WT MQ but not CD1d
2/2 MQ
led to a significant CFU reduction.
doi:10.1371/journal.ppat.1000239.g003
Figure 4. CD69 is upregulated on T cells following culture of splenocytes with Mtb-infected MQ. Splenocytes were cultured with
uninfected (top row) or infected (bottom row) MQ for 24 hrs. Nonadherent cells were recovered and analyzed by flow cytometry. Cells were gated by
size and positive staining with CD1d tetramer (left), CD4 (middle), or anti-CD8 (right). CD69 expression was measured as an indication of cell
activation.
doi:10.1371/journal.ppat.1000239.g004
iNKT Cells and Tuberculosis
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were cocultured with infected MQ.
On day 1 after infection, 7,663 CFU were recovered after the
lysis of Mtb-infected MQ. After three additional days of culture, the
CFU increased 3-fold to 22,587. As previously observed, the
addition of naive splenocytes on day 1 reduced the number of
CFU recovered on day 4 to 9,992 CFU, which represents a 56%
reduction compared to infected MQ alone on day 4 (p,0.05)
(Figure 6A). As addition of splenocytes reduced the number of
CFU close to, but not below the day 1 value, this reduction
represents a suppression of bacterial growth but not killing of Mtb.
Addition of purified iNKT cells reduced the CFU by 88%,
demonstrating that iNKT cells are sufficient to mediate this anti-
bacterial effect (p,0.05, compared to infected MQ alone, day 4)
(Figure 6A). Interestingly, the number of bacteria recovered was
lower even than the number of Mtb recovered on day 1 (68.4%
reduction, p,0.05 compared to infected MQ alone, day 1) (Figure 4).
Thus, not only are iNKT cells necessary and sufficient to restrict
intracellular Mtb replication, but they have the capacity kill Mtb.
Next, we determined whether a physiological number of NKT
cells cultured with infected MQ could have a similar effect. iNKT
cells account for 2–5% of splenocytes in B6 mice, which means
that 100,000–250,000 iNKT cells are present among the five
million splenocytes added to the infected MQ. Thus, we varied the
number of pure iNKT cells from five million to as few as 75,000.
Interestingly, fewer iNKT cells led to higher IFN-c production
(Figure 6B). The number of bacteria remaining in the cultures was
determined on day 3, and even the presence of 75,000 iNKT cells
were able to limit bacterial replication and did so more efficiently
than splenocytes (Figure 6C). Again it was observed that after
infected MQ were cultured with purified iNKT cells for 3 days,
fewer bacteria remained than were present when the iNKT cells
were added (MQ day 1), suggesting that the iNKT cells induced
bacterial killing (Figure 6C).
iNKT Cells Reduce the Bacterial Burden of Mtb-Infected
Mice
Our in vitro results show that Mtb-infected MQ induce iNKT
cell activation, which leads to macrophage production of NO,
which is associated with the suppression of bacterial growth and
perhaps kill Mtb. We have previously shown that CD1d
2/2 mice
are not more susceptible to Mtb infection [7]. To reevaluate the
potential beneficial role of iNKT cells during Mtb infection, NKT
cells were transferred into irradiated C57BL/6 mice, which were
Figure 5. IFN-c production by innate lymphocytes upregulates NO synthesis and is dependent on IL-12 and IL-18. Mtb-infected MQ
were cultured alone or with splenocytes. In addition, some cultures included monoclonal antibodies to IL-12, IL-18, or both, or an irrelevant isotype
control antibody. After 24 hrs, IFN-c (A) and NO2 (B) were measured in the culture supernatant, and after 72 hrs the total CFU were determined (C).
doi:10.1371/journal.ppat.1000239.g005
Figure 6. iNKT cells are sufficient to inhibit intracellular bacterial replication. (A) Mtb-infected MQ were cultured alone or with WT
splenocytes (spln) or with iNKT cells. Bacterial growth in the Mtb-infected MQ was assessed by determining CFU on day 1 and day 4 post-infection. On
day 1, WT splenocytes or the NKT cell line were added to the Mtb-infected MQ, and CFU were determined 72 hrs later on day 4. *, p,0.05, as
determined by a one-way ANOVA with Tukey’s Multiple Comparison Test. (B) Mtb-infected MQ were cultured alone or with WT splenocytes or with
different numbers of NKT cells as indicated. After 24 hours of coculture, IFN-c was measured in the culture supernatants by ELISA. (C) After 72 hrs, the
cultures from (B) were analyzed for the total CFU and compared to Mtb-infected MQ alone on day 1 and day 4. All conditions containing splenocytes
or iNKT cells had significantly (p,0.05) fewer CFU compared to Mtb-infected MQ on day 4 post-infection.
doi:10.1371/journal.ppat.1000239.g006
iNKT Cells and Tuberculosis
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the mice were sacrificed and the CFU in the lung and spleen
determined. A significant CFU reduction was observed in both the
lung and spleen (Figure 7).
To further assess the protective capacity of iNKT cells, we
transferred splenic lymphocytes from uninfected C57BL/6 mice
that were enriched for iNKT cells by depleting cells expressing
CD8 and CD62L (data not shown). As a control, the same cell
population was obtained from Ja281
2/2 mice, which lack iNKT
cells. The cells obtained from WT mice provided protection to
irradiated recipient mice against Mtb (Figure 7). In contrast, the
cells obtained from Ja281
2/2 mice were unable to transfer
protection. These data show that primary iNKT cells that had
never been activated in vitro are capable of protecting immuno-
compromised host from Mtb.
Discussion
We find that Mtb-infected MQ stimulate IFN-c production by
splenocytes. Since the splenocytes are obtained from uninfected
mice that have no previous exposure to Mtb and thus are not
‘‘immune’’ with respect to Mtb antigens, their IFN-c production
must represent activation of an innate pathway. Surprisingly, the
production of IFN-c is dependent on iNKT cells, a minor subset of
T cells that is present in the spleen at a frequency of ,1%. The
biology of iNKT cells has been well described during the past
decade: they are CD1d-restricted T cells that express an invariant
TCRa, rapidly produce cytokines when activated, and modulate a
variety of immune phenomenon [17–19].
How do Mtb-infected MQ activate iNKT cells? There are
several models of how CD1d-restricted T cells become activated.
Presentation of microbial lipid antigen has been described for
certain infectious agents [20–23], and although Mtb antigens are
known for group 1 CD1, and it’s possible that CD1d presents Mtb
ligands, our study does not directly address this possibility. In our
model, iNKT cell effector function is dependent upon CD1d
expression by the infected MQ, indicating that CD1d recognition
is required. Whether a microbial antigen or an endogenous self
lipid antigen is recognized is not certain. Both IL-12p40 and IL-18
are required for the iNKT cell effector function we observe. Thus,
our data is consistent with iNKT cell recognition of a self or
microbial antigen and costimulation by IL-12 and IL-18, two
cytokines which are produced by Mtb-infected MQ. Not only does
IL-12p40 and IL-12p35 form the heterodimeric cytokine IL-
12p70, but IL-12p40 also pairs with IL-23p19, to form the
cytokine IL-23. Since IL-23 is induced by mycobacterial infection
of MQ [24,25], an alternate interpretation of our data is that IL-23
has a role in iNKT cell activation. Following iNKT cell activation,
IFN-c is produced early and stimulates infected MQ to produce
iNOS. This leads to the accumulation of NO, which is associated
with suppression of bacterial growth.
Many studies have described how iNKT cells contribute to
microbial immunity (reviewed in [15,26,27]). iNKT cells are
frequently activated early during infection and secrete IFN-c,
which can have an immunomodulatory role. The use of CD1d
2/2
and Ja281
2/2 mice has clearly revealed that iNKT cells can either
exacerbate or ameliorate the outcome of infection. In addition,
pharmacological activation of iNKT cells with the synthetic ligand
aGalCer often enhances host resistance to infection. iNKT cell use
several mechanisms to modify host immunity. These include
induction of DC maturation, secondary activation of effector cells
(NK cells) or recruitment of inflammatory cells to the site of
infection (PMNs) [28–32]. However, this is the first example of
iNKT cells having a direct effector function against a microbial
pathogen.
Whether CD1d-restricted T cells are required for immunity
against Mtb has been partially addressed by several studies. Both
CD1d
2/2 and Ja281
2/2 mice have been infected with virulent
Mtb by both the IV and aerosol route. All studies to date have
found that the absence of CD1d-restricted T cells do not alter the
outcome to tuberculosis infection in the mouse model [7–11].
Nevertheless, treatment of mice with aGalCer, which specifically
activates iNKT cells, significantly prolongs the survival of infected
mice [14]. In fact, a single dose of aGalCer given the day after
infection prolongs the survival of mice, an endpoint quite remote
from its administration. Thus, it may be that iNKT cells are not
activated optimally in mycobacterial infection but they can alter
the long-term outcome of infection when pharmacologically
activated. A physiological role for this T cell subset early during
infection has been suggested by Szalay et al, who found that
treatment of Mtb-infected mice with anti-CD1 mAb diminished
control of bacterial replication early after IV infection and
correlated with reduced IFN-c and TNF production by Mtb
antigen stimulated splenocytes [33]. While another study found
that anti-CD1d mAb treatment did not worsen the pulmonary Mtb
burden following low dose aerosol infection, early time points were
not examined [8]. Our results are consistent with an early innate
role for iNKT cells in controlling Mtb infection.
Why are CD1d
2/2 mice, which lack the iNKT cell subset, no
more susceptible than WT mice to Mtb infection? There may be
insufficient numbers of resident iNKT cells in the lung to mediate
an anti-mycobacterial effect early during the course of infection.
Although we observed that only a few iNKT cells are needed to
suppress Mtb replication, the statistical probability of finding an
iNKT cell and an infected MQ in the same alveoli is low. In
contrast, once infection is established, iNKT cells are recruited to
the lung and MQ upregulate cell surface CD1d [34]; however, this
is coincident with the appearance of conventional T cells in the
lung, which may overshadow the contribution of CD1d-restricted
T cells. If IFN-c production is the key function of CD1d-restricted
T cells, CD1d and Ja281 ko mice may lack a phenotype because
this function can be mediated by other cell types. Cytokines such
Figure 7. iNKT cells protect mice against Mtb. C57BL/6 mice were
sublethally irradiated and used as recipients in an adoptive transfer
experiment (n=5/group). As a control, one group did not receive any
cells (no transfer). Mice received an iNKT cell line, or splenic
CD8
2CD62L
2 cells from Ja281
2/2 mice or WT C57BL/6 mice. All mice
were infected within 24 hrs with Mtb by the aerosol route. Three weeks
after infection, the bacterial burden in the lung and spleen were
determined. Each point represents data from an individual mouse, and
the bar represents the mean. The comparison between untransferred
mice and mice receiving the NKT cell line was performed twice with
similar results. *, p,0.05 by a one-way ANOVA.
doi:10.1371/journal.ppat.1000239.g007
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cells, and memory CD8 T cells independently of cognate antigen
recognition. Finally, an intriguing observation is the development
of iNKT cell anergy following BCG infection [35] and other
bacterial infections [36]. If iNKT cell anergy were to develop
during Mtb infection, then iNKT cells would appear to make little
or no contribution to immunity against Mtb infection. We
speculate that the basis of the protective effect of aGalCer lies in
its ability to activate iNKT cells before anergy develops.
We established an in vitro model to study innate cellular
mechanisms of immunity against intracellular Mtb. We find that
macrophages infected with virulent Mtb stimulate the IFN-c
production by non-immune splenocytes, which inhibits bacterial
replication. These cellular events are entirely dependent on iNKT
cells forcing us to re-examine the role of CD1d-restricted iNKT
cells in vivo. Using a primary iNKT cell line, we show that iNKT
cells provide protection against low dose aerosol Mtb infection.
These data demonstrate that iNKT cells have a physiological role
in limiting Mtb infection by acting directly as effector T cells.
These findings provide a rationale for understanding how
immunomodulation of CD1d-restricted T cells during Mtb
infection can have a role in the adjuvant therapy of tuberculosis.
Methods
Mice
C57BL/6 (B6) mice were obtained from The Jackson
Laboratory. CD1d knockout (CD1d
2/2) mice on the B6
background were kindly provided by Mark Exley [37]. Ja281
knockout (Ja281
2/2) mice were provided by M. Taniguchi
(Riken, Japan) [38]. Female mice, 7–8 weeks of age, were used
in all experiments. Mice were bred and maintained under specific
pathogen-free conditions and were used in a protocol approved by
the Dana Farber Cancer Institute.
Antibodies and CD1d-PBS57 Tetramers
The following FITC-, PE-, PECy7-, allophycocyanin-, and
PerCP-conjugated anti-mouse mAbs were purchased from BD
Pharmingen: anti-CD8 (PerCP), anti-CD3 (APC), anti-CD69
(PECy7) and anti-CD4 (FITC). Anti-mouse IL-18 was purchased
from MBL, anti-mouse IL-12/IL-23 p40, mouse IgG1 and IgG2A
isotype controls were purchased from RD systems. CD1d-PBS57
and control PE-conjugated tetramers were provided by the
National Institute of Allergy and Infectious Diseases Tetramer
Facility (Emory University Vaccine Center, Atlanta, GA).
Peritoneal MQ and In Vitro Culture
Peritoneal exudate cells were harvested by intraperitoneal
lavage 4 days after intraperitoneal injection of sterile 3%
thioglycolate medium [34]. MQ were purified in a two steps
protocol: B cells were depleted using anti-CD19-microbeads
followed by positive selection of MQ with CD11b-microbeads
(Miltenyi Biotech). The purified cells were .95% F4/80
+
CD11b
+, as determined by flow cytometry. Purified MQ (1610
6)
were seeded into 24-well plates in complete RPMI 1640 medium
(Invitrogen Life Technologies) supplemented with 10% fetal calf
serum (HyClone), penicillin/streptomycin, L-glutamine, sodium-
pyruvate, 2-ME, nonessential amino acids, essential amino acids,
and HEPES buffer (all from Gibco). Recombinant mouse IFN-c
(US Biological) was used at the concentrations indicated.
Bacteria and In vitro Infections
Virulent Mtb (H37Rv) was grown to mid-log phase in
Middlebrook 7H9 medium containing 10% albumin/dextrose/
catalase enrichment (BD Biosciences). Bacteria were opsonized for
2 minutes using RPMI 1640 medium with 2% human serum
(Gemini Bio-Products), 10% FBS, and 0.05% Tween 80 and then
washed twice with complete medium without antibiotics. Bacteria
were passed through a 5-mm syringe filter (Millipore), counted in a
Petroff-Hausser chamber and added to enriched MQ at different
multiplicity of infection (MOI) as indicated. The length on
infection was 2 hr for all experiments. Infected MQ were cultured
overnight before the addition of splenocytes or purified cell subsets
(see below). In some experiments, infected MQ were cultured
overnight in the presence of rIFN-c (2.5 units/ml). The next day
all wells were washed twice with RPMI medium without
antibiotics.
Splenocytes and Cell Enrichment
Spleens were aseptically removed and mechanically homoge-
nized with a 3-ml syringe plunger. Erythrocytes were lysed with
RBC lysis buffer (1 mM KHCO3, 0.15 M NaCl and 0.1 mM
sodium-EDTA [pH 7.3]). Cells were washed and viability
determined using trypan blue. Splenocytes were resuspended in
complete RPMI 1640 medium and unless otherwise specified,
5610
6 splenocytes/well were added to cultures of infected MQ in
24-well plates. T cells (Thy1
+), B cells (CD19
+) and CD4
+ T cells
were enriched using microbeads (Miltenyi Biotec, Auburn, CA).
Enriched NKT cells were prepared by depleting CD8
+ and
CD62L
+ cells from splenocytes using microbeads, and contained
12-15% tetramer
+ T cells.
NKT Cell Line
T cells were negatively isolated from splenocytes of Va14-Ja281
Tg mice by using the Pan T cell isolation kit (Mylteni Biotec).
NKT cells staining with the APC labeled mouse CD1d tetramer
loaded with PBS57 (provided by the NIAID Tetramer Facility)
were sorted by using anti-APC MicroBeads (Mylteni Biotec). Bone
marrow-derived dendritic cells (BM-DC) were grown from bone
marrow progenitors by culture for 6 days in the presence of
granulocyte-monocyte colony stimulating factor (10 ng/ml) and
IL-4 (1 ng/ml) (R&D systems) in complete RPMI medium (RPMI
supplemented with L-glutamine and penicillin/streptomycin; Life
Technologies) containing 10% FBS (Hylone Laboratories). BM-
DCs were pulsed with aGalCer at 100 ng/ml for 24h at 37uC and
then irradiated at 3400 rad. 2610
6 NKT cells were cultured with
2610
5 aGalCer-pulsed BM-DCs per well in 24 well plates in
complete RPMI 1640 medium. 3–5 days later, mIL-2 (10 U/ml)
(R&D Systems) and mIL-7 (10 ng/ml) (PeproTech) were added in
the medium. NKT cell lines were re-stimulated with aGalCer-
loaded BM-DCs every 2–3 weeks. These cells were used for both
in vitro and in vivo experiments.
Blocking Experiments
Cytokine function was blocked by addition of azide-free, low-
endotoxin anti-mouse cytokine-specific mAbs. Infected MQ were
co-cultured with naive splenocytes at a ratio of 5:1 in the presence
or absence of antibodies specific for IL-12 (10 mg/ml, clone C17.8,
R & D) and IL-18 (10 mg/ml, clone 93-10C, MBL) or isotype-
matched control mAb. On day 4 after the infection supernatants
and cells were recovered to analyze IFN-c and NO production,
and bacterial growth.
CFU Determination
Bacterial growth was quantified 24 hrs after MQ infection
(hereafter referred to as day 1) and 72 hr after coculture with naive
splenocytes or splenocyte cell fractions (day 4). After removing the
iNKT Cells and Tuberculosis
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3 min and plating 10-fold dilutions on Middlebrook 7H11 agar
plates. In some experiments, the number of CFU contained in the
supernatant was also determined. The number of bacteria
contained in the supernatant was ,10% of the cell associated
CFU, and this was true whether or not splenocytes or other cell
fractions were added to the infected MQ. The number of colonies
was counted 3 weeks after incubation at 37uC in a humidified CO2
atmosphere.
Cytokine Detection
Culture supernatants were assayed for IFN-c and IL-12p40 by
standard sandwich ELISA. All Ab pairs and standards were
purchased from BD PharMingen, and ELISAs were done in
accordance with the manufacturer’s instructions. Samples were
read at 405 nm on SoftMax Pro ELISA analysis software
(Molecular Devices). IFN-c and IL-12p40 were quantified by
comparison with the appropriate recombinant standard (pur-
chased from BD PharMingen).
NO Production
Supernatants were harvested after 24 hrs of coculture and NO
production was measured using the Griess reaction. Briefly, 100 ml
of culture supernatants were incubated with an equal volume of
commercial Griess reagent (Sigma-Aldrich) for 5 min at room
temperature, and the absorbance was measured at 490 nm. Serially
diluted NaNO2 of known concentration was used as a standard to
calculate the amount of NO2 found in the supernatant [39].
Flow Cytometry
Changes in the phenotype of cells 24 hrs after coculture with
infected MQ was determined by multiparametric flow cytometry.
Recovered cells were resuspended in FACS buffer (2% FCS,
2 mM sodium azide in PBS). To inhibit nonspecific staining, cells
were incubated with 25 mg/ml of anti-FccRII/III Ab (2.4G2) for
10 min at 4uC, washed, and then stained with fluorochrome-
conjugated isotype-matched control IgG or Abs specific for mouse
cellular markers. Cells were also stained with CD1d-PBS57
tetramer in FACS buffer for 15–20 min at 4uC, and then washed
and fixed in 1% paraformaldehyde overnight. Data was collected
using a FACSCanto (BD Biosciences) and analyzed with FlowJo
(Tree Star).
NKT Cell Adoptive Transfer into Mtb-Infected Recipient
Mice
An adoptive transfer system was used to analyze the ability of
NKT cells to mediate protection during pulmonary tuberculosis
infection. B6 mice were sublethally irradiated with 600rads from a
cesium-137 source. The next day, the mice were infected with
virulent Mtb (Erdman strain) via the aerosol route as described
previously [40]. Invariant NKT cells (5610
6/mouse) or enriched
splenic NKT cells (10610
6/mouse) were injected via the tail vein
into the infected B6 mice. Three weeks after infection and
adoptive transfer, the mice were euthanized and their left lung and
spleen were aseptically removed and individually homogenized in
0.9% NaCl-0.02% Tween 80 with a Mini-Bead-Beater-8 (BioSpec
Products, Bartlesville, OK). Viable bacteria were enumerated by
plating 10-fold serial dilutions of organ homogenates onto 7H11
agar plates (Remel). Colonies were counted after 3 weeks of
incubation at 37uC.
Statistical Analysis
Data are shown as mean6standard deviation (SD). Unpaired
student’s test was used to compare two groups and one way
analysis of variance (ANOVA) when more than two groups were
compared. A level of p ,0.05 was accepted as statistically
significant. For the in vivo experiments, CFU were log10
transformed before statistical testing using the non-parametric
Mann-Whitney test. Analysis was performed using Prism 5.0
software (GraphPad Software, Inc., San Diego, CA).
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